Israel Englander’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.21M Sell
417,534
-1,030,352
-71% -$11.1M ﹤0.01% 2786
2026
Q1
$12.2M Buy
1,447,886
+123,639
+9% +$1.35M 0.01% 1973
2025
Q4
$15M Buy
1,324,247
+356,094
+37% +$4.41M 0.01% 1845
2025
Q3
$14.5M Sell
968,153
-659,386
-41% -$9.6M 0.01% 2019
2025
Q2
$23M Buy
1,627,539
+726,281
+81% +$12.9M 0.01% 1444
2025
Q1
$21.7M Buy
901,258
+895,457
+15,436% +$31.6M 0.01% 1431
2024
Q4
$217K Sell
5,801
-172,878
-97% -$8.07M ﹤0.01% 5264
2024
Q3
$8.93M Buy
178,679
+161,771
+957% +$6.29M ﹤0.01% 2286
2024
Q2
$587K Buy
+16,908
New +$669K ﹤0.01% 4495
2023
Q4
Sell
-44,169
Closed -$1.37M 6098
2023
Q3
$1.15M Buy
44,169
+20,695
+88% +$430K ﹤0.01% 4082
2023
Q2
$561K Buy
+23,474
New +$404K ﹤0.01% 4457
2022
Q4
Sell
-1,034,932
Closed -$153M 6575
2022
Q3
$153M Buy
+1,034,932
New +$7.51M 0.09% 169

Other funds holding BHVN

Israel Englander's BHVN Position: Q2 2026 in Review

Israel Englander reduced its Biohaven (BHVN) stake by 71% in Q2 2026, selling an estimated $11.1M and leaving 417,534 shares worth $6.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2786.

Israel Englander first reported a position in BHVN in Q3 2022 and has held it in 12 quarters since. The position peaked at $153M in Q3 2022. 291 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Israel Englander held 417,534 shares of Biohaven worth $6.21M as of Q2 2026.
  • Israel Englander sold 1,030,352 Biohaven shares in Q2 2026, an estimated $11.1M.
  • Biohaven made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2786 holding.
  • Israel Englander first reported a position in Biohaven in Q3 2022 and has held it in 12 quarters since.
  • Israel Englander's Biohaven position peaked at $153M in Q3 2022.
  • 291 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.